 Chromosomal rearrangements and altered expression of this gene have also been implicated in breast cancer.In addition, its decline is associated with poor prognosis, disease progression, increased occurrence of metastasis and increased patient mortality.Although in most cancers it has been found in reduced levels, there are studies that show that in some cases it is overproduced.